Dalagon, Apple Grace P.
HRN: 16-94-77 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/11/2022
CEFUROXIME 500MG (TAB)
09/11/2022
09/17/2022
ORAL
500mg
BID
S/P NSVD; PROM
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes